TherapeuticsMD, Inc. (NASDAQ:TXMD) headquartered in Boca Raton, will host a conference call for the investment community to discuss the 3Q20 earnings result on 9th November 2020 at 8:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.therapeuticsmd.com
Earnings Expectation
TherapeuticsMD, Inc. is set to announce third quarter earning results on Monday 9th November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, TXMD to report 3Q20 loss of $ 0.14 per share. For the full year, analysts anticipate top line of $ 60.63 million, while looking forward to loss of $ 0.63 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 15.10 million ~ $ 15.10 million
Full Year 2020 topline are forecasted in a range of$ 90.00 million ~ $ 110.00 million
Click Here For More Historical Outlooks Of TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a womens health care product company in the United States. The companys hormone therapy drug candidate is the TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil.
